New Customer 5% Off

Copy a coupon code below and apply it when checkout

5%
OFF
New Customer 5% Off
No expiration date
-29.411764705882% PURE HEALTH-PT-141 Click to enlarge

PURE HEALTH-PT-141

$ 48.00

624sold

  • 💥💥Free shipping on orders of $1000 or more!
  • Get it between November 19 ~ November 24
  • Over 18 people have this in their carts right now
  • V*****u in New York, US United States bought this (2 Hours ago)

Total $ 48.00

Recent Orders
—
0
Name
Order
Quantity
Date
Trusted Store
99%Issue-Free
SecureCheckout
$10KID Protect

Payment Security

Privacy Protection

Efficient Shipping

Customer Support

product description

PT-141 (Bremelanotide) – Efficacy & Usage Instructions
Overview
PT-141 (INN: Bremelanotide, branded as Vyleesi) is a synthetic cyclic melanocortin peptide, an analog of alpha-melanocyte-stimulating hormone (α-MSH). It is the first FDA-approved on-demand treatment for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike PDE5 inhibitors that act on peripheral blood flow, PT-141 works centrally on the nervous system to regulate sexual desire.

Mechanism of Action
PT-141 acts as a non-selective agonist of melanocortin receptors, with primary activity on MC3R and MC4R in the central nervous system:

Activates brain pathways that control sexual motivation, desire, and arousal response
Modulates dopaminergic and noradrenergic signaling to enhance sexual drive
Functions independently of the nitric oxide/vascular pathway, making it effective for sexual dysfunction that does not respond to PDE5 inhibitors
Key Benefits & Indications
FDA-Approved Indication
Acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women: Reduces distress caused by low sexual desire, and improves sexual desire, receptivity and arousal.
Common Off-Label Clinical Uses
Reduced libido / low sexual desire in adult men and women
Erectile dysfunction (especially psychogenic ED, or ED unresponsive to PDE5 inhibitors)
Delayed orgasm or blunted sexual arousal response
Dosage & Administration
Standard FDA-Approved Protocol
Single dose: 1.75 mg
Route: Subcutaneous injection (abdomen or thigh)
Timing: Administer at least 45 minutes before anticipated sexual activity; onset at ~45 minutes, peak effect at 1–2 hours
Frequency limits: Maximum 1 dose per 24-hour period; maximum 8 doses per month
Treatment evaluation: Discontinue if no clinically meaningful improvement is observed after 8 weeks of use
Dosing for Lyophilized Compounded Powder
For compounded PT-141 lyophilized vials (common specifications: 5mg / 10mg per vial), clinical practice typically uses a titration regimen:

Starter dose: 0.5 mg per administration, for initial tolerance assessment
Standard dose: 1–1.75 mg per administration, adjusted by individual response and tolerability
Maximum single dose: 2 mg (higher doses significantly increase the risk of adverse effects)
Reconstitution Guide (Lyophilized Vial)
For a 5 mg PT-141 vial:

Reconstitute with 1 mL Bacteriostatic Water for Injection
Final concentration: 5 mg/mL
0.1 mL solution = 0.5 mg PT-141
0.2 mL solution = 1 mg PT-141
0.35 mL solution = 1.75 mg PT-141
Reconstitution steps:

Slowly inject bacteriostatic water along the inner wall of the vial, to avoid direct impact on the lyophilized powder
Gently swirl or slowly invert the vial until full dissolution. Do NOT shake vigorously
Withdraw the required dose with a sterile insulin syringe for subcutaneous injection
Store reconstituted solution at 2–8°C (refrigerated), and use within 30 days for best potency
Precautions & Adverse Effects
Common Adverse Reactions
Nausea (most common, usually mild and transient)
Facial flushing, skin warmth
Transient elevation in blood pressure and heart rate
Headache, fatigue
Local injection site reaction (redness, mild discomfort)
Contraindications & Warnings
Not indicated for postmenopausal women, or for sexual performance enhancement in healthy individuals
Use with caution in patients with uncontrolled hypertension, cardiovascular disease, or history of melanoma
Contraindicated in pregnancy, breastfeeding, and pediatric populations
Do not combine with other melanocortin agonists or hormonal agents without medical supervision
For research and compounding use only. Always follow the guidance of a licensed healthcare provider.

Product NamePURE HEALTH-PT-141
Specification
Purity≥ 99%
FormLyophilized powder
StorageStore at -20°C in a cool, dry place

Reviews are currently unavailable.